| Evolocumab and clinical outcomes in patients with cardiovascular disease G Sabatine, M.S., Giugliano, R.P., Keech, A.C.Schooley, C., Shifrin New England Journal of Medicine 376 (18), 1713-1722, 2017 | 5629 | 2017 |
| Ezetimibe added to statin therapy after acute coronary syndromes CP Cannon, MA Blazing, RP Giugliano, A McCagg, JA White, P Theroux, ... New England Journal of Medicine 372 (25), 2387-2397, 2015 | 4772 | 2015 |
| Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy O De Filippo, F D’Ascenzo, F Angelini, PP Bocchino, F Conrotto, ... New England Journal of Medicine 383 (1), 88-89, 2020 | 1124 | 2020 |
| Vorapaxar in the secondary prevention of atherothrombotic events D Morrow, D.A., Braunwald, E., Bonaca, M.P., Singh, N., Logwood New England Journal of Medicine 366 (15), 1404-1413, 2012 | 1099 | 2012 |
| Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ... European heart journal 41 (22), 2083-2088, 2020 | 1016 | 2020 |
| Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. E Vanoli, GM De Ferrari, M Stramba-Badiale, SS Hull Jr, RD Foreman, ... Circulation research 68 (5), 1471-1481, 1991 | 951 | 1991 |
| Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. PJ Schwartz, E Vanoli, M Stramba-Badiale, GM De Ferrari, GE Billman, ... Circulation 78 (4), 969-979, 1988 | 774 | 1988 |
| Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome PJ Schwartz, SG Priori, M Cerrone, C Spazzolini, A Odero, C Napolitano, ... Circulation 109 (15), 1826-1833, 2004 | 758 | 2004 |
| Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction M Massa, V Rosti, M Ferrario, R Campanelli, I Ramajoli, R Rosso, ... Blood 105 (1), 199-206, 2005 | 673 | 2005 |
| Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial RP Giugliano, TR Pedersen, JG Park, GM De Ferrari, ZA Gaciong, ... The Lancet 390 (10106), 1962-1971, 2017 | 650 | 2017 |
| Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure GM De Ferrari, HJGM Crijns, M Borggrefe, G Milasinovic, J Smid, M Zabel, ... European heart journal 32 (7), 847-855, 2011 | 593 | 2011 |
| Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset … MS Sabatine, LA Leiter, SD Wiviott, RP Giugliano, P Deedwania, ... The lancet Diabetes & endocrinology 5 (12), 941-950, 2017 | 589 | 2017 |
| A short‐term, randomized, double‐blind, parallel‐group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial … JY LE HEUZEY, GM De Ferrari, D Radzik, M Santini, J Zhu, JM DAVY Journal of cardiovascular electrophysiology 21 (6), 597-605, 2010 | 526 | 2010 |
| Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia AAM Wilde, ZA Bhuiyan, L Crotti, M Facchini, GM De Ferrari, T Paul, ... New England Journal of Medicine 358 (19), 2024-2029, 2008 | 435 | 2008 |
| Calmodulin mutations associated with recurrent cardiac arrest in infants L Crotti, CN Johnson, E Graf, GM De Ferrari, BF Cuneo, M Ovadia, ... Circulation 127 (9), 1009-1017, 2013 | 413 | 2013 |
| Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial F Zannad, GM De Ferrari, AE Tuinenburg, D Wright, J Brugada, C Butter, ... European heart journal 36 (7), 425-433, 2015 | 393 | 2015 |
| Long term vagal stimulation in patients with advanced heart failure First experience in man PJ Schwartz, GM De Ferrari, A Sanzo, M Landolina, R Rordorf, C Raineri, ... European journal of heart failure 10 (9), 884-891, 2008 | 355 | 2008 |
| COVID-19 in Europe: the Italian lesson A Saglietto, F D’Ascenzo, GB Zoccai, GM De Ferrari The Lancet 395 (10230), 1110-1111, 2020 | 319 | 2020 |
| Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography R Bugiardini, O Manfrini, GM De Ferrari Archives of internal medicine 166 (13), 1391-1395, 2006 | 312 | 2006 |
| Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a … G Crimi, S Pica, C Raineri, E Bramucci, GM De Ferrari, C Klersy, M Ferlini, ... JACC: Cardiovascular Interventions 6 (10), 1055-1063, 2013 | 285 | 2013 |
